Table 2.
Characteristics of the included studies
| First author, year | Target group | Intervention | Control | Depression measure | HRQoL measure | Follow-Upa |
|---|---|---|---|---|---|---|
| Bosmans 2007 [62] | Primary care elder participants with major depression | Interpersonal psychotherapy = 69 | CAU = 74 | MADRS | EQ-5D-3L SF-36 |
26; 52 |
| Bosmans 2014 [63] | Elder participants in elderly homes at risk for depressive and/or anxiety disorders | Stepped care prevention program = 93 | CAU = 92 | CES-D | EQ-5D-3L | 4; 17; 30; 43 |
| Hermens 2007 [64] | Primary care participants with minor or mild major depression | CAU + antidepressants = 85 | CAU = 96 | MADRS | EQ-5D-3L SF-36 |
6; 13; 52 |
| Huijbregts 2013 [65] | Primary care participants with major depression | Collaborative care = 61 | CAU = 38 | PHQ-9 | EQ-5D-3L | 13; 26; 39; 52 |
| van Marwijk 2008 [66] | Primary care participants with major depression | Program-based disease management = 70 | CAU = 75 | MADRS | EQ-5D-3L SF-36 |
9; 26; 52 |
| Schreuders 2007 [67] | Primary care participants with mental health problems | PST + CAU = 88 | CAU = 87 | HADS-D | EQ-5D-3L SF-36 |
13; 39 |
| Seekles 2011 [68] | Primary care participants with minor/major depression and anxiety disorder | Stepped care = 60 | CAU = 60 | IDS | EQ-5D-3L | 8; 16; 24 |
| van Steenbergen-Weijenburg 2015 [69] | Participants at general hospital with chronic diseases and major depression | Collaborative Care = 42 | CAU = 40 | PHQ-9 | EQ-5D-3L SF-36 |
26; 52; 78; 104 |
| van Straten 2007 [70] | Self-referred participants with depression, anxiety, or work-related stress | Web-based PST = 107 | WL = 106 | CES-D | EQ-5D-3L | 5; 9 |
| Warmerdam 2010 [71] | Self-referred participants with depressive symptoms | Web-based PST = 88; Web-based CBT = 88 | WL = 87 | CES-D | EQ-5D-3L | 5; 8; 12; 39 |
CAU care as usual, CBT cognitive behavioral therapy, CES-D center for epidemiologic studies depression scale, HADS-D hospital anxiety and depression scale, HRQoL health-related quality-of-life, IDS-SR inventory of depressive symptomatology self-report, MADRS Montgomery–Åsberg depression rating scale, PHQ-9 patient health questionnaire, PST problem solving treatment, WL Waiting list
aFollow-up in weeks from baseline